Evolutionary strategy when the incentive ratio changes. par Shuangzhi Zhang (17357579)

Sujets:

Evolutionary strategy when the default amount changes. par Shuangzhi Zhang (17357579)

Sujets:

Effect on evolutionary results when corporate and university expenditures change. par Shuangzhi Zhang (17357579)

Sujets:

The selection strategy of the three parties in GEUS. par Shuangzhi Zhang (17357579)

Sujets:

Research framework. par Shuangzhi Zhang (17357579)

Sujets:

Simulation parameters. par Shuangzhi Zhang (17357579)

Sujets:

Stability discriminant results of GEUS evolutionary strategy. par Shuangzhi Zhang (17357579)

Sujets:

Evolutionary strategy when a party’s willingness to participate changes. par Shuangzhi Zhang (17357579)

Sujets:

Effect on evolutionary results when government revenues and expenditures change. par Shuangzhi Zhang (17357579)

Sujets:

Simulated evolutionary trajectory of GEUS. par Shuangzhi Zhang (17357579)

Sujets:

Rational explanation of the evolutionary strategy. par Shuangzhi Zhang (17357579)

Sujets:

Evolutionary strategy when the allocation ratio changes. par Shuangzhi Zhang (17357579)

Sujets:

General judgment criteria of GEUS. par Shuangzhi Zhang (17357579)

Sujets:

Description of the parameters of the GEUS evolutionary game. par Shuangzhi Zhang (17357579)

Sujets:

Evolutionary strategy when the willingness of three parties to participate changes. par Shuangzhi Zhang (17357579)

Sujets:

The inner logic of GEUS. par Shuangzhi Zhang (17357579)

Sujets:

Mean rate (per 100) of patients of top prescribers experiencing benzodiazepine-related harms at 12 months pre- to 18 months post-intervention–sensitivity analysis. par Meagan Lacroix (16698830)

Sujets:

Data_Sheet_1_Chaperonin TRiC/CCT subunit CCT7 is involved in the replication of canine parvovirus in F81 cells.docx par Xia Su (10888110)

Data_Sheet_1_Chaperonin TRiC/CCT subunit CCT7 is involved in the replication of canine parvovirus in F81 cells.ZIP par Xia Su (10888110)

DataSheet1_Characterization of cardiac involvement in patients with LMNA splice-site mutation–related dilated cardiomyopathy and sudden cardiac death.ZIP par Xuebin Ling (14172333)

“…<p>Introduction:LMNA splicing mutations occur in 9.1% of cases with cardiac involvement cases, but the phenotype and severity of disease they cause have not yet been systematically studied. …”